Variability of the dietary-derived CYP2D6 activity marker solanidine in vivo

被引：0
|
作者：
Mueller, J. P. [1 ]
Saromba, J. [1 ]
Ziegler, P. [2 ]
Tremmef', R. [3 ,4 ]
Rengelshausen, J. [2 ]
Schaeffeler, E. [3 ,4 ]
Just, K. S. [1 ]
Schwab, M. [3 ,5 ,6 ]
Kraus, T. [2 ]
Sting, J. C. [1 ]
机构：
[1] Univ Hosp RWTH Aachen, Inst Clin Pharmacol, Aachen, Germany
[2] Univ Hosp RWTH Aachen, Inst Occupat Social & Environm Med, Aachen, Germany
[3] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[4] Univ Tubingen, Tubingen, Germany
[5] Univ Tubingen, Dept Clin Pharmacol, Tubingen, Germany
[6] Univ Tubingen, Dept Biochem & Pharm, Tubingen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2024年 / 397卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P226
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] Nutrimetric Validation of Solanidine as Dietary-Derived CYP2D6 Activity Marker In Vivo
    Mueller, Julian Peter
    Saroemba, Jens
    Ziegler, Patrick
    Tremmel, Roman
    Rengelshausen, Jens
    Schaeffeler, Elke
    Just, Katja S.
    Schwab, Matthias
    Kraus, Thomas
    Stingl, Julia C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (02) : 309 - 317
  • [2] Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity
    Kiiski, Johanna I.
    Neuvonen, Mikko
    Kurkela, Mika
    Hirvensalo, Paeivi
    Haemaelaeinen, Kreetta
    Tarkiainen, E. Katriina
    Sistonen, Johanna
    Korhonen, Mari
    Khan, Sofia
    Orpana, Arto
    Filppula, Anne M.
    Lehtonen, Marko
    Niemi, Mikko
    HUMAN GENOMICS, 2024, 18 (01)
  • [3] Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity
    Johanna I. Kiiski
    Mikko Neuvonen
    Mika Kurkela
    Päivi Hirvensalo
    Kreetta Hämäläinen
    E. Katriina Tarkiainen
    Johanna Sistonen
    Mari Korhonen
    Sofia Khan
    Arto Orpana
    Anne M. Filppula
    Marko Lehtonen
    Mikko Niemi
    Human Genomics, 18
  • [4] Solanidine as CYP2D6 activity marker in a multi-medicated, geriatric cohort
    Saroemba, J. A.
    Mueller, J.
    Laurentius, T.
    Heimer, C. Bol
    Roeth, A.
    Sting, J.
    Just, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S72 - S72
  • [5] Solanidine is a sensitive and specific biomarker for CYP2D6 activity
    Kiiski, Johanna I.
    Neuvonen, Mikko
    Hirvensalo, Paivi
    Kurkela, Mika
    Hamalainen, Kreetta
    Lehtonen, Marko
    Filppula, Anne M.
    Niemi, Mikko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 132 : 15 - 16
  • [6] Solanidine is a highly sensitive and specific biomarker for CYP2D6 activity
    Kiiski, Johanna I.
    Neuvonen, Mikko
    Filppula, Anne
    Hirvensalo, Paivi
    Kurkela, Mika
    Hamalainen, Kreetta
    Auriola, Seppo
    Lehtonen, Marko
    Niemi, Mikko
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1335 - 1336
  • [7] Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism
    Wollmann, Birgit M.
    Smith, Robert L.
    Kringen, Marianne Kristiansen
    Ingelman-Sundberg, Magnus
    Molden, Espen
    Storset, Elisabet
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 740 - 747
  • [8] Doxepin inhibits CYP2D6 activity in vivo
    Szewczuk-Boguslawska, M
    Kiejna, A
    Beszlej, JA
    Orzechowska-Juzwenko, K
    Milejski, P
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (04): : 491 - 494
  • [9] The effect of TCAs on CYP2D6 activity in vivo
    Szewczuk-Boguslawska, M.
    Kiejna, A.
    Beszlej, J.
    Orzechowska-Juzwenko, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S251 - S251
  • [10] Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients
    Saroemba, Jens Andreas
    Mueller, Julian Peter
    Tupiec, Jolanta
    Roeth, Anjali
    Kurt, Berkan
    Kahles, Florian
    Laurentius, Thea
    Bollheimer, Cornelius
    Stingl, Julia C.
    Just, Katja S.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
12345